22nd Century Group (NYSE MKT: XXII) this morning announced its inclusion to the Russell Microcap® Index. The one-year membership to the index means the plant biotech company is automatically included in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index. Our inclusion will generate further interest in the Company’s stock among those investors in the investment community who may be less familiar with 22nd Century Group,” 22nd Century Group president and CEO Henry Sicignano, III, stated in the news release. Shares of 22nd Century Group are down 2.1% at $1.84, trading in a 52-week range of $0.77-$2.00.
To view the full press release, visit: http://nnw.fm/k00Od
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company focused on genetic engineering and plant breeding which allows the increase or decrease of the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants. The Company’s primary mission in tobacco is to reduce the harm caused by smoking. The Company’s primary mission in cannabis is to develop proprietary hemp/cannabis strains for important new medicines and agricultural crops. Visit www.xxiicentury.com and www.botanicalgenetics.com for more information.
About CBDNewsBreaks
CBDNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of CBDWire (CBDW). NNB keeps you up-to-date on active US Public Companies complementary to CBDW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
Please see full disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, CO
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com